BactiQuant (BACTIQ.CO) Stock Analysis & AI Equity Report
BactiQuant (BACTIQ.CO) overview
BactiQuant (BACTIQ.CO) stock analysis and AI equity research. For the latest completed financial year, 2024, BactiQuant reported revenue of DKK 7.2m and operating profit of DKK -12.6m; the year-end share price was 3.03 DKK and market capitalisation was DKK 79.8m. BactiQuant is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get BactiQuant's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-29. Data will be refreshed during report generation.
About BactiQuant
BactiQuant A/S develops and sells technology for measuring and monitoring bacterial levels in water. Its product range includes online systems and handheld mobile lab solutions used in water utilities, industrial processes, pharmaceuticals, aquaculture, and other water-dependent operations. The company’s value drivers are rapid bacterial detection, improved water quality control, and reduced waste.
Generate the BactiQuant report
BactiQuant is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for BactiQuant and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.